STOCK TITAN

DILLARD'S, INC. SEC Filings

DDS NYSE

Welcome to our dedicated page for DILLARD'S SEC filings (Ticker: DDS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Dillard’s, Inc. files SEC reports that document its retail operations, capital structure, governance and material corporate events. Recent 8-K disclosures cover operating results and financial condition, including sales, gross margin, expenses, inventory and net income measures for the company’s department-store and related businesses.

The filings also identify Class A Common Stock trading on the New York Stock Exchange under DDS and record corporate governance actions, shareholder-rights modifications, the company’s Texas corporate status, amendments to charter-related instruments and material definitive agreements. Proxy-solicitation and shareholder-vote disclosures appear where governance or transaction matters require formal investor communications.

Rhea-AI Summary

Dillard’s (DDS) President and director Alex Dillard reported an insider purchase. On 10/27/2025, he acquired 14 shares of Class A common stock at $623.52 per share. Following the transaction, he beneficially owns 1,018,867 Class A shares directly.

He also reports indirect holdings of 41,496 shares through W.D. Company, Inc., 7,300 shares as trustee of a GST trust, and 36,560 shares owned by his spouse. The filing notes he disclaims beneficial ownership of indirectly held shares except to the extent of his pecuniary interest. W.D. Company, Inc. holds 3,985,776 Class B shares convertible into Class A on a one-for-one basis.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Dillard's (DDS) reported an insider stock purchase by a vice president. On 10/27/2025, the officer acquired 10 shares of Common Class A at $623.52 per share (Transaction Code A).

Following the transaction, the officer beneficially owned 1,281 shares directly. A separate line item shows Common Class A held in a Retirement Plan totaling 7,186 shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Dillard's (DDS) director J C Watts Jr. reported an open-market sale of 750 shares of Common Class A on 10/16/2025 at $594.60 per share. After this transaction, he beneficially owns 10,250 shares held directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Dillard’s (DDS): Notice of proposed insider sale. A holder filed a Form 144 to sell up to 750 shares of Dillard’s common stock. The filing lists an aggregate market value of $442,024.80 and an approximate sale date of October 16, 2025. The shares are slated to be sold on the NYSE through Raymond James & Associates.

The shares to be sold were acquired via stock awards from the issuer on three dates: 400 shares on May 20, 2024, 100 shares on May 19, 2023, and 250 shares on May 22, 2017, with cash noted as the form of payment at acquisition.

The signer represents they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Dean L. Worley, VP/General Counsel & Secretary of Dillard's, Inc. (DDS) reported a purchase on 09/29/2025 of 10 shares of Common Class A at a price of $622.50 per share. After the transaction the filing shows Mr. Worley directly beneficially owns 6,402 Common Class A shares and indirectly owns 3,483 shares through a retirement plan. The Form 4 is signed and dated 10/01/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Phillip R. Watts, identified as a Senior Vice President and officer of Dillard's, Inc. (DDS), reported an open-market acquisition on 09/29/2025 in a Form 4 filing. The filing shows 11 shares of Common Class A were acquired with a transaction code "A" and a reported price of $622.5. After the reported transaction, Mr. Watts is recorded as beneficially owning 8,905 shares directly and 10,317 shares in a retirement plan. The Form 4 is signed by Mr. Watts on 10/01/2025. The disclosure is a routine insider transaction showing a small purchase by a named officer and does not include derivative activity or other transactions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Insider purchase reported: James D. Stockman, Vice President and director-level officer of Dillard's, Inc. (DDS), reported acquiring 13 shares of Class A common stock on 09/29/2025 at a price shown as $622.5 per share. After the transaction he beneficially owned 35,267 shares directly, plus 21,093 shares held in a retirement plan. The Form 4 is signed by the reporting person on 10/01/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Brant Musgrave, Corporate VP Stores at Dillard's (DDS), reported an acquisition on 09/29/2025. He purchased 9 shares of Dillard's Class A common stock at a reported price of $622.50 per share, increasing his direct holdings to 3,631 shares. The filing also shows 8,461 Class A shares held indirectly in a retirement plan. The Form 4 is signed on 10/01/2025 and discloses no derivative transactions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Denise Dillard Mahaffy, a director and Senior Vice President of Dillard's, Inc. (DDS), reported an open-market acquisition of 12 shares of Class A common stock on 09/29/2025 at a price showing $622.5 (per the form entry). After the transaction she is reported to beneficially own 163,496 shares directly and 7,300 shares indirectly via a GST trust for which she is the trustee. The filing is a Form 4 statement of changes in beneficial ownership required under Section 16.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Denise Alexandra Lucie, reported as a Vice President of Dillard's, Inc. (DDS), executed a securities transaction on 09/29/2025. The Form 4 shows an acquisition (code A) of 9 shares of Dillard's Class A common stock at a reported price of $622.50 per share, increasing her direct holdings to 37,022 shares. The filing also discloses 5,068 shares held in a retirement plan (direct) and additional indirect beneficial ownership totaling 38,423 shares held in trust where she is trustee and 13,389 shares held in children’s trusts where she is grantor, as explained in the footnotes. The form is signed and dated 10/01/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many DILLARD'S (DDS) SEC filings are available on StockTitan?

StockTitan tracks 234 SEC filings for DILLARD'S (DDS), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for DILLARD'S (DDS)?

The most recent SEC filing for DILLARD'S (DDS) was filed on October 29, 2025.